EXC
54
3
KMX
61
-3
CINF
53
3
FRT
41
-2
BXP
49
-3
TXN
43
-5
ALL
50
2
GME
66
-5
CAT
59
-2
HBI
58
3
AAL
57
-2
DHI
44
-3
T
48
3
HSY
31
-6
IBM
47
-3
DIS
85
3
DRI
50
-3
IPG
34
-9
ZBH
65
3
WDC
37
-3
EXC
54
3
KMX
61
-3
CINF
53
3
FRT
41
-2
BXP
49
-3
TXN
43
-5
ALL
50
2
GME
66
-5
CAT
59
-2
HBI
58
3
AAL
57
-2
DHI
44
-3
T
48
3
HSY
31
-6
IBM
47
-3
DIS
85
3
DRI
50
-3
IPG
34
-9
ZBH
65
3
WDC
37
-3
Financhill
Back

Geron Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
21

GERN
Geron

Last Price:
3.77
Seasonality Move:
10.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
21
Geron (GERN) is a Sell

Is Geron a Buy, Sell or Hold?

  • The current Geron [GERN] share price is $3.78. The Score for GERN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GERN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GERN Stock Price Chart

What is Geron's stock price today?

  • The Geron share price today is $3.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GERN is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $42.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GERN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 36.78 Sell
Chaikin Money Flow: 4444795 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 26.84 Sell
Chaikin Money Flow: -3822578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.96 - 58.72) Sell
Bollinger Bands (100): (51.86 - 60.48) Sell

GERN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.95 Sell
20-day SMA: 4.07 Sell
50-day SMA: 4.25 Sell
200-day SMA: 3.84 Sell
8-day EMA: 3.89 Sell
20-day EMA: 4.04 Sell
50-day EMA: 4.19 Sell
200-day EMA: 3.87 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.27 Sell
20-day SMA: 54.02 Sell
50-day SMA: 55.85 Sell
200-day SMA: 48.97 Sell
8-day EMA: 52.24 Sell
20-day EMA: 54.19 Sell
50-day EMA: 55.13 Sell
200-day EMA: 50.65 Sell

Geron Earnings Growth & GERN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.23 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Geron Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):